Lamivudine, a nucleoside analogue, has been used in China since 1998, which has brought new hope to the Hepatitis B patients.

• 摘要核苷类似物拉米夫定于1998年在我国上市，为乙型肝炎的抗病毒治疗带来了新的希望。